Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY
DRKS00016043Phase 3Completed
- Sponsor
- Bezirkskliniken Schwaben
- Start
- Dec 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clozapine and olanzapine in schizophrenia (2 arms), sponsored by Bezirkskliniken Schwaben. Started Dec 2018; status: completed.
02
Drugs
clozapineolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on DRKS00016043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00016043.